08:00    Registration, partnering meetings and networking in the exhibition hall

08:40    Welcome and introduction
Moderator: Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology
Samuel Lagercrantz, Editor-in-chief, Life Science Sweden

08:50    Promoting innovation as a leader: Strategies for implementing research and innovation in the healthcare sector
Ann-Marie Wennberg Larkö, Professor in Dermatology and Venereology, Sahlgrenska Academy – Chair of the Board, Forska!Sverige

09:15    Turning the tide of antimicrobial resistance (AMR)
Fredrik Almqvist, Co-founder and CSO, QureTech Bio

09:40    Coffee, partnering meetings and networking in the exhibition hall

10:15    A Hydrogel-based wound dressing for combating antibiotic-resistant infections
Martin Andersson, Professor of Surface Chemistry, Chalmers University of Technology

10:40    The importance of gentle liquid flow – Fluid handling perfected by gravity
Robin Öz, CEO, Ventri Labs

11:05     Exploring novel strategies to target cancer-specific features
Xiaonan Zhang, Docent in Medical Molecular Biology, Uppsala University 

11:30     Lunch, partnering meetings and networking in the exhibition hall

13:00     From Medeon to the World – Transforming the life and future of diabetics
Adam Bruce, CEO and Chairman, Abarceo Pharma

13:25     Developing drugs for kidney disease – it takes re(n)al intelligence
Julie Williams, Chief Scientist, Renal Disease, AstraZeneca  

13:50     Coffee, partnering meetings and networking in the exhibition hall

14:20     Current financial climate for the Swedish life science sector
Filip Einarsson, Equity Analyst – Life Science, RedEye

14:45     Exosomes – the future of modern biological medicines | Exocure – a Gothenburg-based exosome platform company
Jan Lötvall, Professor of Clinical Allergy, University of Gothenburg – Founder, Exocure
Søren Melsing, CEO, Exocure

15:10     Leveraging Atlas Antibodies from the Human Protein Atlas for insights into precision medicine in cancer
Eugenia Kuteeva, Principal Scientist Antibody Development, Atlas Antibodies

15:35     Biomarkers you have never seen before!
Mikael Kubista, Professor, Precision BioAnalytics – Gothenburg University

16:00     Concluding remarks
Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

Approx. 16:05    End of programme